Robert M. Davis's most recent trade in Merck & Co Inc was a trade of 32,462 Common Stock done at an average price of $118.4 . Disclosure was reported to the exchange on Feb. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 118.35 per share. | 04 Feb 2026 | 32,462 | 443,601 (0%) | 0% | 118.4 | 3,841,920 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 117.38 per share. | 04 Feb 2026 | 14,972 | 476,063 (0%) | 0% | 117.4 | 1,757,407 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 107.40 per share. | 26 Jan 2026 | 47,434 | 491,035 (0%) | 0% | 107.4 | 5,094,412 | Common Stock |
| Duke Energy | Robert M. Davis | Director | Grant, award, or other acquisition of securities at price $ 121.33 per share. | 01 May 2025 | 1,607 | 12,660 (0%) | 0% | 121.3 | 194,977 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 181,623 | 181,623 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 39,901 | 39,901 | - | - | Restricted Stock Unit | |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 95,275 | 443,601 (0%) | 0% | 97.9 | 9,331,234 | Common Stock |
| Duke Energy | Robert M. Davis | Director | Grant, award, or other acquisition of securities at price $ 103.06 per share. | 09 May 2024 | 1,698 | 11,053 (0%) | 0% | 103.1 | 175,000 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 181,641 | 181,641 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Robert Davis M. | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 125.74 per share. | 13 Feb 2024 | 124,676 | 373,650 (0%) | 0% | 125.7 | 15,677,147 | Common Stock |
| Merck & Company | M. Davis Robert | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 108,491 | 181,781 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Davis Robert M. | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 13 Feb 2024 | 108,491 | 498,326 (0%) | 0% | 73.7 | 7,999,041 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 85,021 | 96,760 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Davis Robert M. | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 125.40 per share. | 13 Feb 2024 | 85,021 | 348,326 (0%) | 0% | 125.4 | 10,661,574 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 13 Feb 2024 | 85,021 | 433,347 (0%) | 0% | 73.7 | 6,268,598 | Common Stock |
| Merck & Company | M. Robert Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 41,509 | 83,020 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Robert Davis M. | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.36 per share. | 13 Feb 2024 | 41,509 | 389,835 (0%) | 0% | 75.4 | 3,128,118 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 126.37 per share. | 13 Feb 2024 | 25,324 | 348,326 (0%) | 0% | 126.4 | 3,200,277 | Common Stock |
| Merck & Company | M. Davis Robert | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 76,510 | 348,326 (0%) | 0% | 119.4 | 9,137,589 | Common Stock |
| Duke Energy | Robert M. Davis | Director | Grant, award, or other acquisition of securities at price $ 98.15 per share. | 04 May 2023 | 1,783 | 9,354 (0%) | 0% | 98.1 | 175,000 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 186,722 | 186,722 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 28 Apr 2023 | 143,329 | 415,145 (0%) | 0% | 56.0 | 8,032,157 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 114.93 per share. | 28 Apr 2023 | 143,329 | 271,816 (0%) | 0% | 114.9 | 16,472,845 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 143,329 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Robert M. Davis | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 24,224 | 271,816 (0%) | 0% | 109.9 | 2,661,733 | Common Stock |
| Merck & Company | Robert M. Davis | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 167,613 | 415,205 (0%) | 0% | 0 | Common Stock | |
| Merck & Company | Robert M. Davis | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 167,613 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Robert M. Davis | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 101.94 per share. | 09 Nov 2022 | 87,595 | 327,610 (0%) | 0% | 101.9 | 8,929,557 | Common Stock |
| Merck & Company | Robert M. Davis | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 102.98 per share. | 09 Nov 2022 | 79,918 | 247,692 (0%) | 0% | 103.0 | 8,229,924 | Common Stock |
| Merck & Company | Robert M. Davis | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 103.59 per share. | 09 Nov 2022 | 100 | 247,592 (0%) | 0% | 103.6 | 10,359 | Common Stock |
| Duke Energy | Robert M. Davis | Director | Grant, award, or other acquisition of securities at price $ 110.05 per share. | 05 May 2022 | 1,590 | 7,570 (0%) | 0% | 110.1 | 174,980 | Common Stock |
| Merck & Company | Robert M. Davis | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 228,155 | 228,155 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Robert M. Davis | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 29,896 | 247,592 (0%) | 0% | 73.5 | 2,197,655 | Common Stock |
| Duke Energy | Robert M. Davis | Director | Grant, award, or other acquisition of securities at price $ 100.57 per share. | 06 May 2021 | 1,591 | 5,980 (0%) | 0% | 100.6 | 160,000 | Common Stock |
| Merck & Company | Robert M. Davis | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 281,633 | 281,633 | - | - | Stock Option (Right to Buy) |